Determination of adequate tuberculosis regimen in patients hospitalized with hiv-associated severe immune suppression
Conditions:   Tuberculosis;   HIV-1-infection;   Immuno-Deficiency Interventions:   Drug: Intensified TB treatment;   Drug: WHO standard TB treatment Sponsor:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 4, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

INSTI's For The Management of HIV-associated TB
Conditions:   HIV/AIDS;   Tuberculosis, Pulmonary Interventions:   Combination Product: Biktarvy®;   Combination Product: TLD- fixed-drug combination single tablet Sponsors:   Centre for the AIDS Programme of Research in South Africa;   Johns Hopkins University;   National Institute of Allergy and Infectious Diseases (NIAID);   University of Cape Town;   Medical Research Council, South Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Development of Molecular Diagnostic Platform for Tuberculosis
Condition:   Tuberculosis Intervention:   Diagnostic Test: New technique vs Xpert Sponsor:   Asan Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2021 Category: Research Source Type: clinical trials

Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis Interventions:   Drug: Atorvastatin with standard anti tuberculosis drugs;   Drug: Anti tuberculosis drugs only Sponsors:   Obafemi Awolowo University Teaching Hospital;   Birmingham Heartlands Hospital;   Cures Within Reach, USA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2021 Category: Research Source Type: clinical trials

Pulmonary Tuberculosis Sequelae in Patients With COPD
Conditions:   Copd;   Tuberculosis;   Quality of Life Intervention:   Other: Functional Outcome Measurements Sponsor:   Izmir Katip Celebi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Intervention:   Drug: PZA sensitivity guided ultra-short all oral Regimen Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pulmonary Tuberculosis Sequelae in Patients With COPD
Conditions:   Copd;   Tuberculosis;   Quality of Life Intervention:   Other: Functional Outcome Measurements Sponsor:   Izmir Katip Celebi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Intervention:   Drug: PZA sensitivity guided ultra-short all oral Regimen Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pulmonary Tuberculosis Sequelae in Patients With COPD
Conditions:   Copd;   Tuberculosis;   Quality of Life Intervention:   Other: Functional Outcome Measurements Sponsor:   Izmir Katip Celebi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Intervention:   Drug: PZA sensitivity guided ultra-short all oral Regimen Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pulmonary Tuberculosis Sequelae in Patients With COPD
Conditions:   Copd;   Tuberculosis;   Quality of Life Intervention:   Other: Functional Outcome Measurements Sponsor:   Izmir Katip Celebi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Intervention:   Drug: PZA sensitivity guided ultra-short all oral Regimen Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pulmonary Tuberculosis Sequelae in Patients With COPD
Conditions:   Copd;   Tuberculosis;   Quality of Life Intervention:   Other: Functional Outcome Measurements Sponsor:   Izmir Katip Celebi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pyrazinamide;   Drug: Linezolid;   Drug: Cycloserine;   Drug: Clofazimine Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Pulmonary Tuberculosis Sequelae in Patients With COPD
Conditions:   Copd;   Tuberculosis;   Quality of Life Intervention:   Other: Functional Outcome Measurements Sponsor:   Izmir Katip Celebi University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pyrazinamide;   Drug: Linezolid;   Drug: Cycloserine;   Drug: Clofazimine Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials